Heading to Contract Pharma 2026? The Questions Every Pharmaceutical Company Should Ask Its Next CDMO
By Kyle Loethen
Heading to Contract Pharma 2026? The Questions Every Pharmaceutical Company Should Ask Its Next CDMO
You’re Not Hiring a Vendor. You’re Entrusting Your Company’s Future. At CPL, We Understand That.
By Kyle Loethen
Why CPL Is Built for Complex Topical Reformulation Programs
By Kyle Loethen
How CPL Approaches Reformulation for Underperforming Topical Products
By Kyle Loethen
Why Topical Drug Products Underperform After Early Development
By Kyle Loethen
Commercial Oral Liquid Manufacturing: What to Look for in an Outsourcing Partner
By Kyle Loethen
Nasal Spray Manufacturing and Tech Transfer: What Sponsors Should Look for in a Commercial Manufacturing Partner
By Kyle Loethen
Why Many CDMOs Struggle with Semi-Solids and What Sponsors Should Look For Instead
By Kyle Loethen
Why Semi-Solid Formulations Fail in Scale-Up and How to Minimize Risk and Maximize Success
By Kyle Loethen
CPL is Advancing Topicals Through Scientifically Driven Semi-solid Development
By Kyle Loethen